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.v<w );,,1. vru Y,,,!? 
compnrirans be&en Ihe Lwo muups). Recurrent ia.haspiul pin. 
rarcmsry anabnny and need for inlerwnlion showed no relulinn to 
Iho lwls nl these msrken. In 19 sddilkmill plierrb (9 wilh 
unrlablr ansma ad IO control plirnb) ssmp& from Ihe cw(~ 
A rnle for lhrombu5 i;rmaion in ihe pathogenesir of unsu- 
bk angina pecloris is wpported by palholngic C 1.2). angio- 
graphic 13-5) and angioscupic (6; &ala. Binchcmlcal markr;s 
ofthrombus fwnxaiol; have BI\U suggead II\ role in wn: 
pslienrb wilb unsla.blc an~ma and acute myocardisl infarc- 
lion. Elcvabon of these markar relleils either pIal& 
acliwlion 17). acliwion of Ihe coapulslion pathway\ with 
fibnn formatmn. or drrradalion ?f lihrin by plasmin. F;h,ie- 
upeplidc A. an mdexof thrombm a&& fibrinogen. ib 
increased in wne patients hilh unslable angina 181. How- 
ewr. vaIuc~ ovcrlsp u&h ~hosc of paticnrs wilh amble 
angina. Levels of Rtrinlogen) dcyradalion prcduclr like 
D-monomer and D-dimcr. which r&cl the a&i@ of pIa+ 
mm on lihtinogcn and xoss-linked Iii% respectively. have 
been found IO be increo>ed m the peripher4 blood ofpaalierds 
wdh unnable angina. wilhaut averlap with levels of these 
producls in patients with slablr angina (9). Additiona!ly. in 
par!enrs wilh conmary anery dircase and parlialarly in 
patients with acute myocardial infartiion. abnormal fibrin- 
olylic activily due lo an increase in plasminogen aaivaror 
inhihhur hac been rewoned (10-13). 
The purpme of &is study lphzse I) was II 10 define the 
vaiue of wipheral blood \amplinE of the thrombosis-related 
markers bf (ibrin D-dimer and pl&minogen activator inhibi- 
tor in dislinguishing unswblc angina fmm r:abl? angina pecto- 
ris: ?i 10 BIFCIS the re!alion of time cl sampling tier rest pzin 
10 levels of these factors: and 3) 10 relale changes in these 
iactan ui!h the Casey in-huspkai clinical course in patients with 
unst;lhle angina. Because paiphem! hlwd wmples may not 
adequately reflect Ihe aclivily ofthesc markers in the cwwuy 
circuldlicw we alo assessed (phase II) whether sampling of 
these markers from Ihe coronary smut wouid be nwre edica- 
cious in idcptifying patients wilh usable angina than would 
analyzing penpheral samples alone. 
Methods 
Study patients. In phase I of the study we ,WpeCtiVelY 
analyzed D-dimer and plasminogen aclivawr ;nhihitor in the 
penpheral blood of!6 pauen,, v.ah un\,able angma and 6.I 10 
control pa,,m!~ (IS wah >,anlc anf,n;t and 5 expcr~cncmg 
chfs, pain w-h” had normal coronxy anene\l. In phax II of 
the \tudy. we analyxd coronsry ,,no\ and per,pheral hlwd 
wnpler o, an add”,ana, I’, pallem,. N,ne of ,hc,c ~a,,~,\ 
had unrlablc z&a. alrd There acre !O control pd~emx (6 
with stable angina and 4 u t,h che,l pain and normal cororur~ 
anerIe\). 
L’nsruDl,~ wni:u wus defied a\ Ixhcmic che$, pain a, 
~$1 vliln no evidence “I myocdrdrdl arcrow hy rnrymdhc 
techniques. Keverriblc STJ chaage\ uere prexn, on the 
electrocardiogram (ECCI durmg episcdc, of cheu pun We 
wdied only pauesr m whom blood wnphng wd\ porr~hlc 
wirhin 2’ h of res, the\, pain. No patic”, received heparm 
hefore baseline sampling. Subie aogmr ual defined :a* effort 
angina without reccn, dc,criora,ion or rc*l pain in Ihe la\t 6 
months. The c”n,.ol palien& were sclecled from pawn,\ 
hospirahzed dunng Ihe ,ame penod for elrclivc cardiac 
ca,he,eriz;lti”n. 
All pa,ien,s gave mformed c”n*ex. The \udy ua\ xp- 
proved by the hospi,al‘a Human Studies Comrmt,ee 
Blood sampling. For each p&n, whh un~ublc angnu m 
phase 1. a baseline sample was coi!ec,cd a$ cod> d\ p<:whle 
after res, pain and 24 1” 48 h later. In I6 of the 26 paiientr. 
baseline blood was drawn wthm 6 h of WA :sm and en h oi 
the 26 patients. baseline blood uas draur uxhm I h of pa! 
Control patients in phase I had a harehne blood \smpL 
drawn at cardiac catheterizarlon wrh a,rwma,x renr~wr- 
tore or through an indwelhng peopheral \healh. before 
hepannization. 
In ,,hose II. a 6F. heparin-bonded end hole catheter ,,a\ 
inscned from a left anrecuhital vein and poriluxxd 31 the 
proximal end of the coronary smu under prerrure guidrnce 
and flaoroscop,c control. and IS ml of blond za$ wthdraan 
before hepariniration. The umr caihelcr wa5 ,hcn *ah.. 
drawn into the left suhclavian vein fur prnpheral umphng. 
which was complcwd <5 ma” after comnrrp vow vamphn~ 
Six oFmoe patienls wh uwahle anem., had coronary rmur 
samples drawn within 6 h of re*\t pam: m three of Ihe mne. 
samples were drawn wthin I h of pain. For all sample> the 
inaial3 1” 5 ml wan diwarded. Blood for fihri” D-dimer \ra\ 
collected in EDTAIPPACKiapr”,min: >“dum s!,ra,c tube\ 
wilhou, anapr”,ea% protecuon were whzed for pl~~mmo- 
Se” ac,,va,“r mhzh,,or. 
Biuchemic:d analysis. Immrd8ale ~e”~rJu~~iwn uf ail 
blood samples was performed a, 3.000 rpm for I? mm a, 
WC. The plasma cas bepawed immedlatel? a”” 5,ored a, 
-20°C. Fibrin D-dimer (wlmll ~a\ meawred uah an 
ELlSA lAmencao Diagn”~,xal and plasminogen acuwtor 
inhihilor W!ml) wh a functional neu,rdlira,ion dwv c 141. 
This asray measure\ rapld mhlhmo;, of ,we plavn~nopen 
activator which cooMule, primrril) plnvninopn actwator 
mhlbitar-I. Sample> were analyzed a1 the Umvcrrq of 
Vermont uohou, knowledge of the climcal data or coronary 
anpiographic Endmgs. Nurmal \&es m ,hl\ lah”ra,ory xc 
C!inical nh~.wvr+,io% Af,er entry inlo ,he sludy all phase 
I pdhcn,\ uah unuablc angma were oh$erved in the hospital 
for warren, cher, pain or myocardlal ~mlarc,mn and ,he 
loued Ior pcrcwaneou~ coronary angioplasy or :or”nary 
ar,er> bypar, rurpery. 
Stalislirs, m&u&. The ch,.square test and the nonpara- 
m:lric Wilcoxon ICI, were “*cd for compariwn of discrete 
&ml coolinuoos vanable% becueen groupa. Values are ex- 
pw~ed ar mean values +_ SD or median and range. 
Clinical charac,eristie~. Pauenlr wi,h unr,ahle angina 
peclori\ wre not statistically differen, m age and male/ 
%m.de w’o horn the c”n,r”l group: 65 * IO versus 64 ? IO 
jcdrr Jnd I!‘11 verw 150. re5peclivelg. Medical therdpysi 
,he lime of mlaal blood sampling did no, diBer berween the 
Iwo group,. Wuemr w,h unsrable angina were taking zi- 
trater in = !JI. calcium an,ag”m\,~ fn = 2,). beta-adrenergic 
hlockine wen,\ (n = I?, and aspuin In = 12). Palientr in ,he 
control group were laking nitrates In = 91. calcium amago. 
nirls In : Ihi. baa-blocker\ (n = 131. and asolrin (n = 51. 
Fihrin D.dimer and plasminogen acli~ator inhibitor valuff. 
tiarclm~ value% of Abnn D-dimer and plarminogen ac,wa,“r 
mhlbilor IICI~ wnilar in patzen,\ wilh unrrable angina and 
control p,mrn,r (Fig. IL Mean baszlinc valuer : SD 
lmcdranl for D-dimer were 0.09 C 0.06 (0.07l &nl in 
pawn,\ wnh unvahle anginaandO.11 i 0.1010 051 &ml in 
conlroi pdwnw mean barehne values for plarminogen acli- 
valor inhihaor wcrc 9.1 5 9 6 IS.YJ IUlml in oa,ien,s with 
un~lnhlenn~~naand 5.5 _L 1.915.01 IUlml (p = kS1 incomrol 
p*Ucnl\. in conIr”l patis”,* *hh rtable Qngiila. wloes for 
both study markers were simdx 1” lhosc of patients with 
normal coronary arteries. In the patiea,~ with unstable 
anpma. blood samples drawn 24 1” 48 h af,cr initial samp!ing 
did no, direr from ,he baseline values Wig. I). In addition, 
sample\ I!! pd,ien,r with unsiable an+ draw G ,G I h after 
re,, pain were Gmilar 1” samples dmun 4 LO 6 h after rep, 
pm trahle IL In three p&Is with unstable angina, 
plarmimgcn acliwor inhihhor was >20 W/ml: fibrin D-di- 
mer ralue\ m rhese lhree palienlr were similar lo those of 
palien,\ allh plaFmin”gen activa,or inhibitor <ill IUiml. 
Furdxrmorc. blood rsmpler in these three pxI!cm\ uerc 
collcckd 5 10 9 h after an cpwdr of rest pain. 
There wa\ nu rckdion in patients with unstable angina 
bclwecn plaminogcn x~ivalor inhfhltor lcvcl~ nnd lime of 
samplinj! Plwnmogen aciivrdor mhlbilor levcl~ drawn be 
luecn 7300 and IOM AM were rimilsr lo levek drawn 
bawccn 3:OQ and 6:OQ PM. However. in ?Oconlrol paticntr. 
plarminqcn octivalor anhihitor lcvcls drawn before 
II:00 AM wcrc higher lhan lc~els drawn afkr ?:@I PM. 
although this ddkrcncu was not ripnificanl 16.8 ? 2.R verw 
4.! + 5.0 IUlml. re\pectivelyl. 
Angiographic characleridicr. The number Of diw.xd 
vessels was similar in each group. Multiverrel disease wa$ 
prcscnl in 20 (77%) of 26 patientswith unstable angina and in 
IO 167%) of IS patients wh stable angina. The prince ofa 
type II eccentric lesion or an inlracoronary thromhus could 
nol be differentiated on the bait of ditTerencc~ in fibrin 
D-dimcr or plasminopcn aclivator inhibitor IcvcI% 
Clinical followup. Lcurrwt rest pain over 48 h war 
obwrved in I? nf ?h tntienlr with unstable armina. Patienti 
with ad wilhuul rec’urrem chest pain had &ix bareline 
levels of D-dimer and olasminoeeo aclivalor inhibitor (Table 
I B. In addition. the change in th; studied variables uver 24 to 
48 h wa* simdar I” paticntr with and n,ithouL recurrent reel 
pain. Of Ihe three patient\ with plarminogen activator mhib- 
iior 220 IUlml. none had recurrenl in-hospital chest pain. 
Percutaneous coronary angioplasly was required in 5 
p;dwnt~ and coronary anery bypass surgery in 13 patients 
wilh unstable angina. Nodi~Terences in the baseline valuesof 
Ihc studied vari~bler were found between patients who did 
or did nal have a subsequent intervenlion (Table Il. 
Plm~ II (Tuhlc~ 2. Fi,y. 2 and 3) 
Coronary sinus Y~RUS peripheral bhwl kvels. D-dimer 
and plaminogen activator inhibilor levels did not differ in 
the coronary sinus and peripheral bled either 01 patients 
wth unrlable angina OF of ptiems wilh stable angina and 
normal coronary anerics. The differences between periph- 
rral and coronary sinus D-dimer and plasminogen aclivator 
inhihhor levels were also similar between pa!ienLs with 
uustablc angina and cunLrul patients. Furthermore. coronary 
anatomy and Ihc presence of a type II eccentric lesion or 
lhrombur (found in four of nine patten~s with un\!able 
angina) showed no relation LO the levels of there marker\ in 
the coronary sinus samples. From visual analysis of Figure 
2.5 of 9 patients with unstable angina had D-dim.% value\ of 
>O.IZ &ml compared with only 2 of IO control patienrr. 
These patients with unstable angina could oo~ be doTerem- 
ated clinically or angiographicaliy from patients with un\& 
bk anginawho had D-dimer values CO.12 &ml. In Ihe three 
patients with unsrable angina who had blood rnmples draun 
CI h afbzr rest pain. neither corona) VWI nor penpheral 
blood levels of Ddimer differed from levels m patxntr 
whose bbxd wab sampled > I h after chc>l pan. 
Discussion 
Yrerious PIudieS. In prewoua rtudie\. elewliunl of fibrin 
D-dmxer. hhrmlogeo! degradation produe% and fibrmopep- 
ode h have heen found in some pallera wth unstable angina 
and acuw mwcarda! infarcuoa. However. D-dimcr Icvcl~ 
were elwdcd only mfrequently duringihe fi151 24 h of acute 
myocard~al ~nldrcwm 10 paneor, rreatcd convenlionally by 
Lew et al. (IhI. Nevenhrlesr. Kruskel et al. 19) found 
con\~~lenlly mcreased levels of D-dimer. D-monamcr and 
fibrm mnnomer in pawn\ wh unarable angina or BCULC 
myocardial mfxclion. without overlap with galucs in pa- 
lienir wth \lable angma or other control groups. Marked 
overlap ul Ihc observed values of hhrinopepltde A in patientr 
wrh unstable and stable angina was also reported by Thcr- 
oux et al. IX). The diCrenccr among [here soidles may in 
pan be related LO dilferences in the paienr\ studied. timing 
of blood wmplmg in reialion 10 Ihe acute event and the 
va;i~ble wb*iances and analyw\ utilized. 
Rale of plasminogrn activator inhibitor. Plabminogen ac- 
owlor mhlhoor is present in cndothelial cells and ib also 
secreted b) &vared platelels. Its role in the pathogenests of 
acute coronary syndromes ic controversial. Scvcral studies 
C IO-131 have reponed higher levels of plasminogen activator 
mhlbmw !n par~enlr after myocardial infarction. Lncrea~cr in 
plarmmogen activator inhibitor in the II day of acute 
myocardlal mfxelion may be the result ratherthan Ihe eawz 
of acot~ infaction ,171. althoueh some investizators (I01 
q.m~,l~on u helher 11 i5 an acute phase reactant. In a previous 
repon from our laborawry (IS). plasminogen aclivator inhib- 
!fur level\ wre found 10 be variably elevated dunng acme 
m)ocardlal mfarcrion. Recenrly. Sohel 1191 reemphasized 
the imporlawe of pla,minogen aclivaor mhlbaor in acue 
nwoordral mfarctmn. 
Thrombuwelaled markers in unstable versus stable an- 
Rioa. ‘The prnenl study shows that the thrcmbus-related 
markcrr D-dimerand plaminogen activalorinhibitor appear 
unable 10 dwnguish unstable from stable angina pecloris. 
Even when blood was sampled rhonly after an episode of 
rc\L pam or in close proximity 10 rhe venous drainage of the 
coronary anc:y from Ihe coronary sinus. no ii~nifzant 
dli?erencer uere noted. Funhermore. the early in-bospilal 
cluxal courre of p&em, with unstable angina could not be 
predlctcd b? elevations of either of these markers. The 
rearon, for rhe diUerences to the results of pe:ipheral 
wmplr, tilwcen this study and that of Kruskal ct al. 19) are 
not appareni bol possibly are related 10 differences in the 
population wdied or in the methods used. The arrays used 
m tour \tudv differed from those of Krurkal et s! (91. 
Howewr. with Ihe \ame assays used in the presen! study. 
increan awe reported in plarminogen activator inhibitor 
C iXl and D-dlmerlS!ump et al.. unpublished obsewationsf in 
the mqwily of patients with awe myocardnl infarction. 
,Allbouph analysts of plasminogen activator inhnbitor has 
been reponed In patients wilh acute myocardial infarction. 
10 our knowledge there are no previous data on Ihe analyG$ 
of plasminogen acwalor mhibilor m patients wilh unsmble 
dogina. AS menooncd. ocr wdy could not demonstrate an 
increase m plavmnogen iactivotor inhibiror in palicnlr with 
unstable angina pector~ even when bload war wwpled from 
the coronary sinus. Ahhough acme myocardial infarction 
and unstable angina pectori> appear to share o common 
pathogeacsir in mosl caxr. it is likely lhal the amount of 
inlmcoronary lhrombus in parienls with unstable angina 
peetori\ is too small lo be detected by eilber of the ~rsys 
used or lhal tbrombi in unstable angina arc predominamly 
composed of platelcls and no, fibrin. That the amoum of 
lhromhor may be less in patients with unstable angina 
pecwir than m pabems with Q wave infarclion is supported 
by anglographlc studies thal show rignificanlly less lotal 
coronary occlusion on angiography in the “culprit” anery in 
the former group than in patiems wirh acmc myocardial 
infarction l?O.?lL Funhcrmore. studies (22-241 on Ihrom- 
bolytic therapy in uwtable angina pectoris have usually 
shown liltle if any angiognphic improvement after Ihrom- 
bolysis in most patients whose irchcmia-rclaled anery was 
less than lotally occluded before ioilialioo of lherapy. Al- 
though Ihe number of patients whh coronary sinus sampimg 
in our wdy was small and only three patients had coronary 
sinus blood drawn within I h of rest pain. it is unclear at 
presenl whether these assays can ever detect brief episodes 
of ~ymptornatic irchcmia in unstable angina pectoris. 
Palhogenelic vet-w irlwmic mwhanisms in unslable an. 
gins. Allhough the pathogenesis of unstable angina is usa. 
ally relmed lo plaque dlsruprion and ihrombus formalion. 
there is no coosenso~ as lo the mechanisms of ischemia in 
this syndrome. II is unknown whether symplomalic &hernia 
in unstable angina is primarily related to imermittenl acme 
lhrombus formation. pla!elet aggregation. transient in- 
creased vasornotor lone. transient increased myocardial 
oxygen demand or a combmalion ofthere 125). Because il is 
likely that the mechwdsms of symptomatic rest irchcmia in 
unstable angina pccloris arc muitifoctorial. simolvmeous 
analysis of thrombus-related marlers and platelet-derived 
vasoconslnctor subslances like urinary thrombuxane deriv- 
atives. and conlinuous monitoring of heart rmr 2nd b!ood 
pressure 1261 will be necessary IO answer these questions. 
Furthermore. a5 most episodes of rest ischemia II” uoslable 
angina are silem on 24 h KG mooiloring. differenriauon of 
the mcchanirms responsible for siienr versus painful irche- 
mia should also be invest&Wed. 
Study limitations. I, The assays showed a wide tw~ge of 
values for both phases of Ihe study. Although median and 
mean values for D.dtmer and plasminogen activator inhibilo: 
were not significantly diffcrcnr between pa!ieots with onsla- 
ble angina and control pa:ients. Fiaures I and 2 show marked 
variability. We could.nol ide& clinic-l or angiognphtc 
correlates of this vrriability and cannor exclude rhc poasi- 
hility that other facton. e.g.. activation. of platelets by 
vempunctore. conuibuted in some cases o elevation of 
levels ofplasminogen activator inhibitor. Even the sampling 
limes for plasminogen activator iri3itor did not apwar 10 
be responsible for the variable Icvcl~ Wiumal variation of 
pla$mmogen activator inhibilor.1 has been prewoasiy re- 
parted 1271. In thir latlrr study, plasminobeen hclivalor inhib- 
ihor levels were significantly higher in the mxniog than m the 
evening in comrol subjects and in patients wilh pyeviour 
mywordial infarction or unwhle angina. 
?I Jhr lud 01 si~nijrorr diflewnces in rhew raurkvs 
berween purimrs wilb nnsruble un,@nn and conrrol pulienfs 
wggertr that symptomatic res! ischemia May be unrelaled to 
elevations 01 these markers and therefore may be unrelated 
to an epi&ic thrombalic process. However, other markers 
may hve shown differences. Had we chosen to measure 
librinopeptide A or thrombin-anlilhrombin 111. or both. Ihe 
resull~ may have differed from those demonslraled in oar 
rludy. Both librinopeplide A and thrombin-antahrombio III 
reflecl thrombin aclivation. The study markers wc analyzed 
in this rtudy arc markers ofactivation of plasmin rather than 
of th:ombin. While rhere ML few data on thmmbin- 
aolilhmmbin 111 128). fibrinopeptide A has been shown (29) 
to be sensitive but not emirely specific for intravascular 
thrombosis. Because the amount of intracoronary lhrombus 
in unstable angina probably is small. we suspect that idemi- 
fication of a sensitive and specific thrombos-related marker 
in unstable angina will be difficoll if not impossible. 
3) l’nrirn,~ mtdied wirb msrabk ongina included m/y 
patimfs wirh wsf on,@m. Asymplomatic episodes of ische- 
aia were not analyzed because 24 h monitoring was not part 
of the study protocol. If we had chosen lo analyze patients 
with asymptomatic as well as symptomatic ischemia. signif- 
icani differences may have been found betwin the group 
with unslable angina and the control group ‘or wilhin the 
group wilh unstable angina. Subsequent investigations 
should analyze both painful and painless rest &hernia in 
unstable angina. 
Coneiusions. Although previous reporls have suggesled 
that Ihere may be a biochemical marker of thrombas forma- 
tion in patiems whh unstable angina. peripheral and even 
coronary sinus bled samples of D-dimer and plasminogen 
activalor inhibitor in our study could nor distinguish paiems 
with unstable angiaa from conlrol patients. These data do 
,101 necessarily negate the importance ofthmmhus formation 
in the pathwenesis of unstable angina pcctoris. Nevenhe- 
ICES. they suggest either that there may be a critical mass of 
ihrombus necessary 10 elevate those markrn or that symp- 
tomztic rest ischemia in unstable angina may be unrelacd to 
ongoing acute thromhur formation. Comparisons of thmm- 
bus-related markers whb platelet-mediated substances (e.g., 
thromboxane) and hemodynamic variables will be necessary 
10 understand which mechanism or mechanisms may be 
responsible for rest irchemia in (his syndrome. 
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